THE INVITRO AND INVIVO ACTIVITY OF CIPROFLOXACIN

被引:158
作者
ZEILER, HJ [1 ]
GROHE, K [1 ]
机构
[1] BAYER AG,RES & DEV,D-5090 LEVERKUSEN,FED REP GER
关键词
D O I
10.1007/BF01977490
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:339 / 343
页数:5
相关论文
共 5 条
  • [1] INVITRO ACTIVITY OF CIPROFLOXACIN, NORFLOXACIN AND NALIDIXIC-ACID
    BAUERNFEIND, A
    PETERMULLER, C
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1983, 2 (02) : 111 - 115
  • [2] INVITRO ANTI-BACTERIAL ACTIVITY OF AM-715, A NEW NALIDIXIC-ACID ANALOG
    ITO, A
    HIRAI, K
    INOUE, M
    KOGA, H
    SUZUE, S
    IRIKURA, T
    MITSUHASHI, S
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (02) : 103 - 108
  • [3] PIPEMIDIC ACID, A NEW ANTIBACTERIAL AGENT ACTIVE AGAINST PSEUDOMONAS-AERUGINOSA - INVITRO PROPERTIES
    SHIMIZU, M
    TAKASE, Y
    NAKAMURA, S
    KATAE, H
    MINAMI, A
    NAKATA, K
    INOUE, S
    ISHIYAMA, M
    KUBO, Y
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1975, 8 (02) : 132 - 138
  • [4] INVITRO ACTIVITY OF BAY-09867, A NEW QUINOLINE DERIVATIVE, COMPARED WITH THOSE OF OTHER ANTI-MICROBIAL AGENTS
    WISE, R
    ANDREWS, JM
    EDWARDS, LJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (04) : 559 - 564
  • [5] [No title captured]